NEWS
Blog
Inside the Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology
29 February 2024
Jim Geraghty
Thousands of rare diseases, most of genetic origin, were long ignored by a pharmaceutical industry that judged them too small...
Read More
2023 In Review
21 December 2023
Here we provide highlights of our progress and achievements during the year.   As we bid farewell to 2023, we...
Read More
Employee Spotlight Series: Charlie Lay
20 November 2023
In this new series, we wanted to provide a spotlight on some of our employees! Culture is an important part...
Read More
Employee Spotlight Series: Srinath Krishnamurthy
29 September 2023
In this new series, we wanted to provide a spotlight on some of our employees! Culture is an important part...
Read More
Navigating ESG as a Biotech Company
24 April 2023
Miguel Silva
Environmental, social and governance (ESG) metrics are now ubiquitous in the reporting of public companies in the US and UK....
Read More
2022 In Review
23 December 2022
OMass Therapeutics
Here we provide highlights of our progress and achievements during the year. The past twelve months have included many notable...
Read More
Meet Our New Board Members: Diana Bernstein
3 August 2022
OMass Therapeutics
In this new series, we are introducing the new additions to the OMass Board of Directors following our latest round...
Read More
Meet Our New Board Members: Laia Crespo
27 June 2022
OMass Therapeutics
In this new series, we are introducing the new additions to the OMass Board of Directors following our latest round...
Read More
The OMass Mass-spec Club
22 June 2022
A.B. "Benjo" Paterson
As part of our all-hands meeting on the 16-17th of June 2022, we hosted a talent show to celebrate all...
Read More
Meet Our New Board Members: Scott Biller
16 June 2022
OMass Therapeutics
In this new series, we are introducing the new additions to the OMass Board of Directors following our latest round...
Read More
EDI, business success and jigsaw puzzles
30 May 2022
Hsin Loke
Written by: Hsin Loke Last week I was part of a panel at BioTrinity to discuss “Future Proofing Your Business...
Read More